| 发明名称 | Cancer therapy | ||
| 摘要 | An agent that stimulates antiviral immunity may be used, for the treatment of cancer. A product comprising an immunostimulant and a vector comprising a transgene that promotes death of neoplastic cells, may also be used for simultaneous, sequential or separate administration in the treatment of cancer. | ||
| 申请公布号 | US9603912(B2) | 申请公布日期 | 2017.03.28 |
| 申请号 | US201013392570 | 申请日期 | 2010.09.23 |
| 申请人 | Glrotherapy Limited | 发明人 | Farries Timothy;Eckland David |
| 分类号 | A61K39/00;A61K48/00;G01N33/53;G01N33/50;G01N33/68;A61K38/45 | 主分类号 | A61K39/00 |
| 代理机构 | Pharmaceutical Patent Attorneys, LLC | 代理人 | Pharmaceutical Patent Attorneys, LLC |
| 主权项 | 1. In a method of treating cancer in a human by partial or complete resection of tumor from said human, the improvement comprising: a. Determining the level of immunity against a viral vector, and then b. Confirming said human has a measurable level of immunity against said vector, and then c. Administering to said human said viral vector. | ||
| 地址 | Chinnor GB | ||